Pathogens | Free Full-Text | A Summary of the SARS-CoV-2 Vaccines and Technologies Available or under Development | HTML
COVID-eVax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19 | bioRxiv
Applied DNA COVID-19 Collaboration Partner Takis Biotech Receives Italy Ministry of Health Approval to Begin Testing of a Vaccine Candidate on Pre-Clinical Models - Applied DNA Sciences
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
Applied DNA, Takis Biotech Partner To Design COVID-19 Vaccines For Animal Testing
Home
8 Biotechs With Coronavirus Vaccines In Development
Coronavirus outbreak: Top coronavirus drugs and vaccines in development
/GettyImages-1185509424-c266dcf1b8da47a49db6e29b8546c63e.jpg "Top Biotech Stocks for Q2 2022")
Top Biotech Stocks for Q2 2022
News
The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate - Applied DNA Sciences
Coronavirus outbreak: Top coronavirus drugs and vaccines in development
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
Potential coronavirus vaccine candidate discovered by Italian researchers
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV | Business Wire
Home
Applied DNA and Takis Biotech Expand COVID-19 Vaccine Development Program to Include 5th Candidate - Applied DNA Sciences
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect
Repurposed Drugs, Molecular Vaccines, Immune‐Modulators, and Nanotherapeutics to Treat and Prevent COVID‐19 Associated with SARS‐CoV‐2, a Deadly Nanovector - Dube - 2021 - Advanced Therapeutics - Wiley Online Library
Home
Home
3 Biotech Stocks Join the Coronavirus Fight | Nasdaq
Applied DNA Sciences Subsidiary, LineaRx, and Takis Biotech Collaborate for Development of a Linear DNA Vaccine Candidate Against Wuhan Coronavirus 2019-nCoV - Applied DNA Sciences
Coronavirus outbreak: Top coronavirus drugs and vaccines in development
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models - ScienceDirect
